Daytrana

Once-daily preparations of medications used to treat AD/HD have become the standard of care. Concerta (OROS methylphenidate) and Focalin XR (dexmethylphenidate) are effective for approximately 12 hours, and Adderall XR (extended-release mixed amphetamine salts) is effective for 10 - 12 hours.

People with AD/HD have symptoms all day faraway, but taking medications several times a day, particularly at school or at work, is inconvenient, is frequently “forgotten,” and can be stigmatizing. Some public taking multiple doses of shorter-acting preparations feel as whether they are on an “emotional rollercoaster,” with symptoms increasing and decreasing as each dose is wearing off and the next dose is starting to work.

AD/HD is a life problem, not a school or work problem, and longer-acting preparations help public to normalize their life. Daytrana, a transdermal methylphenidate preparation, allows for a increasingly flexible duration of effect - the longer you keep the patch on, the longer the effect.

Fast facts approximately Daytrana:

Daytrana is a clear adhesive patch containing methylphenidate that is applied to intact skin. Each area of the patch contains the same amount of medication, and dose is adjusted by wearing different patch sizes and by varying the wear day. It is available in four doses: 10, 15, 20, and 30 mg.

The 10 mg patch releases 1.1 mg of methylphenidate per hour and contains 27.5 mg per patch; the 15 mg patch delivers 1.6 mg/hr and contains 41.3 mg; the 20 mg patch delivers 2.2 mg/hr and contains 55 mg; and the 30 mg patch delivers 3.3 mg/hr and contains 82.5 mg of methylphenidate.

Daytrana is applied to the hip for nine hours. The mean peak concentrations of methylphenidate is nearly two times higher with Daytrana than with other once-daily methylphenidate preparations, thus the effective dose of Daytrana is often lower than an effective dose of Concerta or somewhat equivalent to an effective dose of Focalin XR.

Peak concentrations were additionally higher with Daytrana with chronic administration compared to peak concentrations after a one dose, and were higher in 6 year olds than in 12 year olds.

Daytrana is generally effective approximately two hours after the patch is applied. It should always be applied to intact skin, as application to inflamed skin increases the rate and extent of absorption, with peak concentrations up to 3 times higher. Heat should not be applied to the patch after application, as it would additionally increase the rate and extent of

absorption of medication. Daytrana should always be applied to the hip as different areas of the body have different absorption rates. The patch should be removed after approximately 9 hours, and the medication remains effective for approximately 3 hours after its removal.

Potential side effects to Daytrana are similar to other methylphenidate preparations and include nausea, abdominal cramping, headache, nasopharyngitis, decreased appetite and weight loss, affect lability (increased sensitivity, emotional instability), tearfulness, insomnia, increased tics, and nasal congestion.

Daytrana is a skin irritant and the majority of society will develop erythema (redness) at the patch site that causes little discomfort. On rare occasions, contact sensitization could develop, and edema, papules, vesicles and other intense skin reactions could occur in addition to erythema. whether such a reaction occurs, the patch should be removed and the doctor should be contacted. Patients who develop allergic contact dermatitis to Daytrana might develop an allergic reaction to methylphenidate in general, and might not be able to subsequently take oral methylphenidate.

Applying the Patch Properly

Daytrana is normally started at the 10 mg dose, soon after the dose is increased weekly until there is an appropriate effect. The patch should be placed on a clean, dry area of the hip and the skin should not be oily, damaged, or irritated. The waistline should be avoided as the patch might be rubbed off by clothing. The alternate hip should be used the following day. The patch should be held firmly in place with the palm of the hand for approximately 30 seconds to produce certain there is good contact. After application, bathing or swimming don’t affect patch adherence. whether a patch does fall off, a new patch can be placed at a different site, but the total daily moment of use shouldn’t exceed nine hours. whether a shorter duration of effect is desired, or whether insomnia occurs, the patch can be removed earlier than 9 hours. The patch can additionally be removed early whether someone experiences initial side effects, which would lower the total daily dose received and might decrease side effects until tolerance to them can develop.

Methylphenidate and other stimulants should not be used by public with heart disease, glaucoma, tics, by someone with meaningful anxiety, tension, or agitation, by someone taking a monoamine oxidase inhibitor (MAOI), or by someone with a history of psychosis. Daytrana has not been studied in children below six years old.
Original post by Richard Sogn, MD